Surety® is a neuraxial system designed by award-winning UK syringe manufacturer, InterVene Limited in response to the NPSA's 'purchasing for safety' initiative for neuraxial (spinal and epidural) medical devices with safer connectors to further minimise wrong route errors. 

We recognise that to achieve a quick and substantial uptake from healthcare professionals it is important to collaborate with other manufacturers. With this in mind, Surety® is available to industry partners without exception and at low cost. 

With the Surety® system manufacturers now have access to a viable and incredibly effective solution whose implementation enables healthcare organisations to be in a position to comply with the NPSA alert by the proposed deadline date of April 2011.

Download the NPSA alerts by clicking on the images above.

Having already successfully brought to market a full range of reverse Luer enteral syringes, InterVene is well aware of the effects of an NPSA alert on the UK healthcare industry. 

Surety® has already generated significant interest from a number of industry partners. If you represent a manufacturer and are interested in integrating the Surety® system then we would be delighted to meet with you to discuss the roll out of the concept in more depth.